Well, I would love to hear if anything special was asked during question time, but I am feeling positive.
We basically have a solid reason now for the low number of tests last report. We all thought 'they signed up these providers, and we are seeing no corresponding revenue, therefore signing up providers means very little and the sales plan is failing'. In reality, we really don't know how much of a sales boost those networks have given as it clearly takes a long time before things start rolling. I am hoping for a much bigger spike in revenue in the next report to correlate with this information. CMS coverage may not be as required as people are thinking based on this info, but that is just pure speculation. We have to wait and see.
They have once again confirmed their 5 year plan is on track. At least they are sticking to their guns here. Presumably they can see the slow but steady increases in sales and are happy with what is going on. They have reaffirmed they are investing in themselves to bring about this goal. Sales team increases, new products, etc.
Good to hear triage is apparently out this year (will be interesting to see that it is) but also interesting that no mention was made of CxColorectal. They are clearing focusing in one area and have decided this is the best path to getting the cashflow positive.
Its all 'more of the same', which is not exciting, but ultimately should mean good things long term. I think they are missing their chances to keep their shareholders up to date and happy regarding sales traction but ah well.